Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Post-Partum and Non-Post-Partum Relapsing Graves’ Hyperthyroidism Display Different Response to Anti-Thyroid Drugs
source: European Journal of Endocrinology / European Federation of Endocrine Societies
authors: Rotondi M, Capelli V, Coperchini F, Pinto S, Croce L, Tonacchera M, Chiovato Lsummary/abstract:
Graves’ disease (GD) patients in remission after a full course of methimazole (MMI) therapy are at risk for a relapse of hyperthyroidism during the post-partum (PP) period, but whether this relapse may display any peculiarity is still unknown. Aim of this study was to compare GD patients undergoing a relapse of hyperthyroidism either in the PP period or not.
We retrospectively evaluated forty-three GD female patients in their childbearing age who experienced a relapse of hyperthyroidism. Eighteen of them relapsed in the PP period (i.e. within 12 months after delivery, PP group); the remaining 25 relapsed elsewhere during life (NPP group).
Age at relapse, thyroid volume, thyroid function tests, TRAb titers, smoking habit, presence and degree of orbitopathy and duration of methimazole (MMI) treatment did not differ in the two groups. However, the remission rate was much greater (79%) in the PP as compared with the NPP (32%) group (P = 0.002). A significant reduction in TRAb levels occurred at 12-month MMI treatment in the PP (F = 9.016; P = 0.001), but not in the NPP group (F = 2.433; NS). At 12 months, the PP group had significantly lower mean TRAb levels (0.6 ± 1.1 U/L and 4.5 ± 4.7 U/L in the PP and the NPP group, respectively; P = 0.029).
Relapsing Graves’ hyperthyroidism in the PP period is more prone to undergo a remission after a second course of MMI treatment. In these patients, a conservative therapeutic approach is more appropriate.
A Validated Tool Can Predict Risk of Developing Thyroid Eye Disease During Antithyroid Drug Treatment of Graves’ D...Over-activity of the thyroid gland, call...
Most Graves’ Disease Treated With Antithyroid DrugsAdults with Graves’ disease are more l...
Management of Graves’ Disease: A ReviewImportance: Graves disease is the most ...
Medication for Graves’ Disease in ChildrenDoctors at Hassenfeld Children’s Hospi...
Natasha’s Story – HyperthyroidismNatasha completed the London Marathon in...
Cancer Incidence and Mortality After Radioiodine Treatment for Hyperthyroidism: A Population-Based Cohort StudyBackground: Radioiodine is used increas...
Management of Endocrine Disease: Arguments for the Prolonged Use of Antithyroid Drugs in Children With Graves’...Graves' disease is an autoimmune disorde...
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.